Compatibilità
Salva(0)
Phase Ib/II trial of TG4001 (Tipapkinogene sovacivec), a therapeutic HPV-vaccine, and Avelumab in patients with recurrent/metastatic HPV16 positive cancers
B. Grellier, et al.
ESMO-AI 2025
Abstract available on ESMO-AI website – Download the abstract – Download the Poster
Menu
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.
alcyon
